Lipocine Statistics Share Statistics Lipocine has 5.42M
shares outstanding. The number of shares has increased by 0.05%
in one year.
Shares Outstanding 5.42M Shares Change (YoY) 0.05% Shares Change (QoQ) 0% Owned by Institutions (%) 9.68% Shares Floating 5.26M Failed to Deliver (FTD) Shares 77 FTD / Avg. Volume 0.14%
Short Selling Information The latest short interest is 100.39K, so 1.88% of the outstanding
shares have been sold short.
Short Interest 100.39K Short % of Shares Out 1.88% Short % of Float 1.93% Short Ratio (days to cover) 3.16
Valuation Ratios The PE ratio is 3119.51 and the forward
PE ratio is -1.92.
Lipocine's PEG ratio is
-31.18.
PE Ratio 3119.51 Forward PE -1.92 PS Ratio 2.33 Forward PS 28.3 PB Ratio 1.24 P/FCF Ratio -19.87 PEG Ratio -31.18
Financial Ratio History Enterprise Valuation Lipocine has an Enterprise Value (EV) of 20.29M.
EV / Sales 1.81 EV / EBITDA -18.21 EV / EBIT -16.61 EV / FCF -15.47
Financial Position The company has a current ratio of 14.75,
with a Debt / Equity ratio of 0.02.
Current Ratio 14.75 Quick Ratio 14.75 Debt / Equity 0.02 Debt / EBITDA -0.39 Debt / FCF -0.33 Interest Coverage 0
Financial Efficiency Return on Equity is 0.04% and Return on Invested Capital is -4.98%.
Return on Equity 0.04% Return on Assets 0.04% Return on Invested Capital -4.98% Revenue Per Employee $699.88K Profits Per Employee $522 Employee Count 16 Asset Turnover 0.5 Inventory Turnover n/a
Taxes Income Tax 681 Effective Tax Rate 7.54%
Stock Price Statistics The stock price has increased by -27.18% in the
last 52 weeks. The beta is 1.24, so Lipocine's
price volatility has been higher than the market average.
Beta 1.24 52-Week Price Change -27.18% 50-Day Moving Average 3.2 200-Day Moving Average 3.89 Relative Strength Index (RSI) 36.04 Average Volume (20 Days) 56,450
Income Statement In the last 12 months, Lipocine had revenue of 11.2M
and earned 8.35K
in profits. Earnings per share was 0.
Revenue 11.2M Gross Profit 3.85M Operating Income -1.16M Net Income 8.35K EBITDA -1.11M EBIT -1.16M Earnings Per Share (EPS) 0
Full Income Statement Balance Sheet The company has 6.21M in cash and 438.63K in
debt, giving a net cash position of 5.77M.
Cash & Cash Equivalents 6.21M Total Debt 438.63K Net Cash 5.77M Retained Earnings -199.77M Total Assets 18.58M Working Capital 16.97M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.22M
and capital expenditures -90.09K, giving a free cash flow of -1.31M.
Operating Cash Flow -1.22M Capital Expenditures -90.09K Free Cash Flow -1.31M FCF Per Share -0.25
Full Cash Flow Statement Margins Gross margin is 34.35%, with operating and profit margins of -10.31% and 0.07%.
Gross Margin 34.35% Operating Margin -10.31% Pretax Margin 0.08% Profit Margin 0.07% EBITDA Margin -9.95% EBIT Margin -10.31% FCF Margin -11.71%
Dividends & Yields LPCN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 0.03% FCF Yield -5.03%
Dividend Details Analyst Forecast The average price target for LPCN is $9,
which is 208.2% higher than the current price. The consensus rating is "Buy".
Price Target $9 Price Target Difference 208.2% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 0.37 Graham Upside -87.33%
Stock Splits The last stock split was on May 12, 2023. It was a
backward
split with a ratio of 1:17.
Last Split Date May 12, 2023 Split Type backward Split Ratio 1:17
Scores Altman Z-Score -8.45 Piotroski F-Score 4
